▶ 調査レポート

トランスフォーミング成長因子の世界市場

• 英文タイトル:Global Market Study on Transforming Growth Factors: Oncology Research Application to Lead Market Growth

Persistence Market Researchが調査・発行した産業分析レポートです。トランスフォーミング成長因子の世界市場 / Global Market Study on Transforming Growth Factors: Oncology Research Application to Lead Market Growth / MRC2110B019資料のイメージです。• レポートコード:MRC2110B019
• 出版社/出版日:Persistence Market Research / 2021年9月30日
• レポート形態:英文、PDF、345ページ
• 納品方法:Eメール
• 産業分類:バイオ
• 販売価格(消費税別)
  Individual User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,124,800 (USD7,600)▷ お問い合わせ
  Corporate User¥1,568,800 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、トランスフォーミング成長因子の世界市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、需要分析・予測、価格分析・予測、製品別(アクチビン、骨形成タンパク質(BMP)、TGF-ベータタンパク質)分析、グレード別(GMP、非GMP)分析、用途別(腫瘍学研究、血液学研究、創傷治癒研究、皮膚科研究、心血管疾患・糖尿病)分析、エンドユーザー別(製薬・バイオテクノロジー企業、研究センター・学術研究所、CMO・CDMO)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・市場背景
・新型コロナウイルス感染症の危機分析
・需要分析・予測
・価格分析・予測
・トランスフォーミング成長因子の世界市場規模:製品別(アクチビン、骨形成タンパク質(BMP)、TGF-ベータタンパク質)
・トランスフォーミング成長因子の世界市場規模:グレード別(GMP、非GMP)
・トランスフォーミング成長因子の世界市場規模:用途別(腫瘍学研究、血液学研究、創傷治癒研究、皮膚科研究、心血管疾患・糖尿病)
・トランスフォーミング成長因子の世界市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、研究センター・学術研究所、CMO・CDMO)
・トランスフォーミング成長因子の世界市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法

Transforming Growth Factor Market – Scope of Report

The latest publication by Persistence Market Research on the global transforming growth factor market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market.

The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for transforming growth factor products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the transforming growth factor market.

The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the transforming growth factor market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the transforming growth factor market offers information divided into five important segments – product, grade, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

[Product]
Activin
Bone Morphogenetic Proteins (BMPs)
TGF-beta Proteins

[Grade]
GMP Grade
NON-GMP Grade

[Application]
Oncology Research
Hematology Research
Wound Healing Research
Dermatology Research
Cardiovascular Disease & Diabetes
Cell Therapy and Ex Vivo Manufacturing
Others

[End User]
Pharmaceutical and Biotechnology Companies
Research Centers & Academic Institutes
CMOs and CDMOs

[Region]
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Form Innovation / Development Trends

4. Key Success Factors

4.1. Key Regulations

4.2. Key Promotional Strategies

4.3. Value Chain Analysis

4.4. Gross Margins Analysis

4.5. Key Regulation: FDA Drug Approval Process

4.6. Regulatory Scenario

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP outlook

5.1.2. Global Healthcare Spending Outlook

5.1.3. Global Cosmetic Procedures Outlook

5.2. Forecast Factors – Relevance & Impact

5.2.1. Growing Contract Research Activities

5.2.2. Technological Advancements in Cell Culture applications

5.2.3. Increasing funding in life science research

5.2.4. Adoption of Growth Factors in Cell therapy and Ex vivo manufacturing

5.2.5. Launch of New Product

5.2.6. Adoption of Growth Factors for oncology research

5.2.7. Growing Research and Academic Institutes

5.2.8. Increasing focus on oncology research

5.2.9. Increasing assay developments for drug discovery

5.2.10. Increasing Application in Regenerative Medicine

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

6.1. Current COVID19 Statistics and Probable Future Impact

6.2. Current GDP Projection and Probable Impact

6.3. Current Economic Projection as compared to 2008 Economic analysis

6.4. COVID19 and Impact Analysis, by Country

6.5. 2021 Market Scenario

6.6. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Transforming Growth Factor Market Demand (In Volume Units) Analysis 2016–2020 and Forecast, 2021–2031

7.1. Historical Market (Volume) Analysis, 2016–2020

7.2. Current and Future Market (Volume) Projections, 2021–2031

7.2.1. Y-o-Y Growth Trend Analysis

8. Global Transforming Growth Factor Market – Pricing Analysis

8.1. Regional Pricing Analysis

8.2. Pricing Break-up

8.2.1. Manufacturer Level Pricing

8.2.2. Distributor Level Pricing

8.3. Global Average Pricing Analysis Benchmark

9. Global Transforming Growth Factor Market Demand Value (US$ Mn) Analysis 2016–2020 and Forecast, 2021–2031

9.1. Historical Market Value (US$ Mn) Analysis, 2016–2020

9.2. Current and Future Market Value (US$ Mn) Projections, 2021–2031

9.2.1. Y-o-Y Growth Trend Analysis

9.2.2. Absolute $ Opportunity Analysis

10. Global Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031, By Product

10.1. Introduction / Key Findings

10.2. Historical Transforming Growth Factor Market (US$ Mn) By Product, 2016–2020

10.3. Current and Future Transforming Growth Factor Market (US$ Mn) Analysis and Forecast By Product, 2021–2031

10.3.1. Activin

10.3.2. Bone Morphogenetic Proteins (BMPs)

10.3.3. TGF-beta Proteins

10.4. Market Attractiveness Analysis By Product

11. Global Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031, By Grade

11.1. Introduction / Key Findings

11.2. Historical Transforming Growth Factor Market (US$ Mn) Analysis By Grade, 2016–2020

11.3. Current and Future Transforming Growth Factor Market (US$ Mn) Analysis and Forecast By Grade, 2021–2031

11.3.1. GMP Grade

11.3.2. NON-GMP Grade

11.4. Market Attractiveness Analysis By Grade

12. Global Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031, By Application

12.1. Introduction / Key Findings

12.2. Historical Transforming Growth Factor Market (US$ Mn) Analysis By Application, 2016–2020

12.3. Current and Future Transforming Growth Factor Market (US$ Mn) Analysis and Forecast By Application, 2021–2031

12.3.1. Oncology Research

12.3.2. Hematology Research

12.3.3. Wound Healing Research

12.3.4. Dermatology Research

12.3.5. Cardiovascular Disease & Diabetes

12.3.6. Cell therapy and Ex vivo manufacturing

12.3.7. Others

12.4. Market Attractiveness Analysis By Application

13. Global Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031, by End User

13.1. Introduction

13.2. Historical Transforming Growth Factor Market (US$ Mn) Analysis By End User, 2016 – 2020

13.3. Current Transforming Growth Factor Market (US$ Mn) Analysis and Forecast By End User, 2021 – 2031

13.3.1. Pharmaceutical and Biotechnology Companies

13.3.2. Research Centers & Academic Institutes

13.3.3. CMO and CDMO

13.4. Market Attractiveness Analysis By End User

14. Global Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031, by Region

14.1. Introduction

14.2. Historical Transforming Growth Factor Market (US$ Mn) Analysis By Region, 2016 – 2020

14.3. Current Transforming Growth Factor Market (US$ Mn) Analysis and Forecast By Region, 2021 – 2031

14.3.1. North America

14.3.2. Latin America

14.3.3. Europe

14.3.4. East Asia

14.3.5. South Asia

14.3.6. Oceania

14.3.7. Middle East and Africa (MEA)

14.4. Market Attractiveness Analysis By Region

15. North America Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031

15.1. Introduction

15.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

15.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031

15.3.1. By Country

15.3.1.1. U.S.

15.3.1.2. Canada

15.3.2. By Product

15.3.3. By Grade

15.3.4. By Application

15.3.5. By End User

15.4. Market Attractiveness Analysis

15.5. Market Trends

15.6. Key Market Participants – Intensity Mapping

16. Latin America Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031

16.1. Introduction

16.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020

16.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031

16.3.1. By Country

16.3.1.1. Brazil

16.3.1.2. Mexico

16.3.1.3. Argentina

16.3.1.4. Rest of Latin America

16.3.2. By Product

16.3.3. By Grade

16.3.4. By Application

16.3.5. By End User

16.4. Market Attractiveness Analysis

16.5. Market Trends

16.6. Key Market Participants – Intensity Mapping

17. Europe Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031

17.1. Introduction

17.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

17.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031

17.3.1. By Country

17.3.1.1. Germany

17.3.1.2. Italy

17.3.1.3. France

17.3.1.4. U.K.

17.3.1.5. Spain

17.3.1.6. BENELUX

17.3.1.7. Russia

17.3.1.8. Rest of Europe

17.3.2. By Product

17.3.3. By Grade

17.3.4. By Application

17.3.5. By End User

17.4. Market Attractiveness Analysis

17.5. Market Trends

17.6. Key Market Participants – Intensity Mapping

18. South Asia Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031

18.1. Introduction

18.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

18.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031

18.3.1. By Country

18.3.1.1. India

18.3.1.2. Thailand

18.3.1.3. Indonesia

18.3.1.4. Malaysia

18.3.1.5. Rest of South Asia

18.3.2. By Product

18.3.3. By Grade

18.3.4. By Application

18.3.5. By End User

18.4. Market Attractiveness Analysis

18.5. Market Trends

18.6. Key Market Participants – Intensity Mapping

19. East Asia Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031

19.1. Introduction

19.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

19.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031

19.3.1. By Country

19.3.1.1. China

19.3.1.2. Japan

19.3.1.3. South Korea

19.3.2. By Product

19.3.3. By Grade

19.3.4. By Application

19.3.5. By End User

19.4. Market Attractiveness Analysis

19.5. Market Trends

19.6. Key Market Participants – Intensity Mapping

20. Oceania Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031

20.1. Introduction

20.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

20.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031

20.3.1. By Country

20.3.1.1. Australia

20.3.1.2. New Zealand

20.3.2. By Product

20.3.3. By Grade

20.3.4. By Application

20.3.5. By End User

20.4. Market Attractiveness Analysis

20.5. Market Trends

20.6. Key Market Participants – Intensity Mapping

21. Middle East and Africa Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031

21.1. Introduction

21.2. Historical Market Value (US$ Mn) Trend Analysis By Value Taxonomy, 2016–2020

21.3. Market Material (US$ Mn) Forecast By Market Taxonomy, 2021–2031

21.3.1. By Country

21.3.1.1. GCC Countries

21.3.1.2. Turkey

21.3.1.3. South Africa

21.3.1.4. Rest of Middle East and Africa

21.3.2. By Product

21.3.3. By Grade

21.3.4. By Application

21.3.5. By End User

21.4. Market Attractiveness Analysis

21.5. Market Trends

21.6. Key Market Participants – Intensity Mapping

22. Key & Emerging Countries Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031

22.1. U.S. Transforming Growth Factor Market Analysis

22.1.1. By Product

22.1.2. By Grade

22.1.3. By Application

22.1.4. By End User

22.2. Canada Transforming Growth Factor Market Analysis

22.2.1. By Product

22.2.2. By Grade

22.2.3. By Application

22.2.4. By End User

22.3. By End User Brazil Transforming Growth Factor Market Analysis

22.3.1. By Product

22.3.2. By Grade

22.3.3. By Application

22.3.4. By End User

22.4. Mexico Transforming Growth Factor Market Analysis

22.4.1. By Product

22.4.2. By Grade

22.4.3. By Application

22.4.4. By End User

22.5. U.K. Transforming Growth Factor Market Analysis

22.5.1. By Product

22.5.2. By Grade

22.5.3. By Application

22.5.4. By End User

22.6. Germany Transforming Growth Factor Market Analysis

22.6.1. By Product

22.6.2. By Grade

22.6.3. By Application

22.6.4. By End User

22.7. France Transforming Growth Factor Market Analysis

22.7.1. By Product

22.7.2. By Grade

22.7.3. By Application

22.7.4. By End User

22.8. Italy Transforming Growth Factor Market Analysis

22.8.1. By Product

22.8.2. By Grade

22.8.3. By Application

22.8.4. By End User

22.9. Spain Transforming Growth Factor Market Analysis

22.9.1. By Product

22.9.2. By Grade

22.9.3. By Application

22.9.4. By End User

22.10. BENELUX Transforming Growth Factor Market Analysis

22.10.1. By Product

22.10.2. By Grade

22.10.3. By Application

22.10.4. By End User

22.11. Russia Transforming Growth Factor Market Analysis

22.11.1. By Product

22.11.2. By Grade

22.11.3. By Application

22.11.4. By End User

22.12. China Transforming Growth Factor Market Analysis

22.12.1. By Product

22.12.2. By Grade

22.12.3. By Application

22.12.4. By End User

22.13. Japan Transforming Growth Factor Market Analysis

22.13.1. By Product

22.13.2. By Grade

22.13.3. By Application

22.13.4. By End User

22.14. South Korea Transforming Growth Factor Market Analysis

22.14.1. By Product

22.14.2. By Grade

22.14.3. By Application

22.14.4. By End User

22.15. ASEAN Transforming Growth Factor Market Analysis

22.15.1. By Product

22.15.2. By Grade

22.15.3. By Application

22.15.4. By End User

22.16. Australia Transforming Growth Factor Market Analysis

22.16.1. By Product

22.16.2. By Grade

22.16.3. By Application

22.16.4. By End User

22.17. New Zealand Transforming Growth Factor Market Analysis

22.17.1. By Product

22.17.2. By Grade

22.17.3. By Application

22.17.4. By End User

22.18. GCC Countries Transforming Growth Factor Market Analysis

22.18.1. By Product

22.18.2. By Grade

22.18.3. By Application

22.18.4. By End User

22.19. South Africa Transforming Growth Factor Market Analysis

22.19.1. By Product

22.19.2. By Grade

22.19.3. By Application

22.19.4. By End User

23. Market Structure Analysis

23.1. Market Analysis by Tier of Companies

23.2. Market Concentration

23.3. Market Share Analysis of Top Players

23.4. Market Presence Analysis

23.4.1. Regional footprint of Players

23.4.2. Product foot print by Players

23.4.3. Channel Foot Print by Players

24. Competition Analysis

24.1. Competition Dashboard

24.2. Pricing Analysis by Competition

24.3. Competition Benchmarking

24.4. Competition Deep Dive

24.4.1. GE Healthcare

24.4.1.1. Overview

24.4.1.2. Product Portfolio

24.4.1.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.1.4. Sales Footprint

24.4.1.5. Strategy Overview

24.4.1.5.1. Marketing Strategy

24.4.1.5.2. Drug Strategy

24.4.1.5.3. Channel Strategy

24.4.2. Thermo Fisher Scientific

24.4.2.1. Overview

24.4.2.2. Product Portfolio

24.4.2.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.2.4. Sales Footprint

24.4.2.5. Strategy Overview

24.4.2.5.1. Marketing Strategy

24.4.2.5.2. Drug Strategy

24.4.2.5.3. Channel Strategy

24.4.3. Lonza Group AG

24.4.3.1. Overview

24.4.3.2. Product Portfolio

24.4.3.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.3.4. Sales Footprint

24.4.3.5. Strategy Overview

24.4.3.5.1. Marketing Strategy

24.4.3.5.2. Drug Strategy

24.4.3.5.3. Channel Strategy

24.4.4. Merck KGaA

24.4.4.1. Overview

24.4.4.2. Product Portfolio

24.4.4.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.4.4. Sales Footprint

24.4.4.5. Strategy Overview

24.4.4.5.1. Marketing Strategy

24.4.4.5.2. Drug Strategy

24.4.4.5.3. Channel Strategy

24.4.5. F. Hoffmann-La Roche Ltd

24.4.5.1. Overview

24.4.5.2. Product Portfolio

24.4.5.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.5.4. Sales Footprint

24.4.5.5. Strategy Overview

24.4.5.5.1. Marketing Strategy

24.4.5.5.2. Drug Strategy

24.4.5.5.3. Channel Strategy

24.4.6. Abcam plc.

24.4.6.1. Overview

24.4.6.2. Product Portfolio

24.4.6.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.6.4. Sales Footprint

24.4.6.5. Strategy Overview

24.4.6.5.1. Marketing Strategy

24.4.6.5.2. Drug Strategy

24.4.6.5.3. Channel Strategy

24.4.7. Bio-Techne.

24.4.7.1. Overview

24.4.7.2. Product Portfolio

24.4.7.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.7.4. Sales Footprint

24.4.7.5. Strategy Overview

24.4.7.5.1. Marketing Strategy

24.4.7.5.2. Drug Strategy

24.4.7.5.3. Channel Strategy

24.4.8. Sartorius CellGenix GmbH

24.4.8.1. Overview

24.4.8.2. Product Portfolio

24.4.8.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.8.4. Sales Footprint

24.4.8.5. Strategy Overview

24.4.8.5.1. Marketing Strategy

24.4.8.5.2. Drug Strategy

24.4.8.5.3. Channel Strategy

24.4.9. Proteintech Group, Inc.

24.4.9.1. Overview

24.4.9.2. Product Portfolio

24.4.9.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.9.4. Sales Footprint

24.4.9.5. Strategy Overview

24.4.9.5.1. Marketing Strategy

24.4.9.5.2. Drug Strategy

24.4.9.5.3. Channel Strategy

24.4.10. PeproTech Inc.

24.4.10.1. Overview

24.4.10.2. Product Portfolio

24.4.10.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.10.4. Sales Footprint

24.4.10.5. Strategy Overview

24.4.10.5.1. Marketing Strategy

24.4.10.5.2. Drug Strategy

24.4.10.5.3. Channel Strategy

24.4.11. Cell Signaling Technology, Inc.

24.4.11.1. Overview

24.4.11.2. Product Portfolio

24.4.11.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.11.4. Sales Footprint

24.4.11.5. Strategy Overview

24.4.11.5.1. Marketing Strategy

24.4.11.5.2. Drug Strategy

24.4.11.5.3. Channel Strategy

24.4.12. Meridian Bioscience Inc.

24.4.12.1. Overview

24.4.12.2. Product Portfolio

24.4.12.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.12.4. Sales Footprint

24.4.12.5. Strategy Overview

24.4.12.5.1. Marketing Strategy

24.4.12.5.2. Drug Strategy

24.4.12.5.3. Channel Strategy

24.4.13. Applied Biological Materials (abm), Inc.

24.4.13.1. Overview

24.4.13.2. Product Portfolio

24.4.13.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.13.4. Sales Footprint

24.4.13.5. Strategy Overview

24.4.13.5.1. Marketing Strategy

24.4.13.5.2. Drug Strategy

24.4.13.5.3. Channel Strategy

24.4.14. Akron Biotech

24.4.14.1. Overview

24.4.14.2. Product Portfolio

24.4.14.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.14.4. Sales Footprint

24.4.14.5. Strategy Overview

24.4.14.5.1. Marketing Strategy

24.4.14.5.2. Drug Strategy

24.4.14.5.3. Channel Strategy

24.4.15. Leadgene Biomedical, Inc

24.4.15.1. Overview

24.4.15.2. Product Portfolio

24.4.15.3. Profitability by Market Segments (Drug/Channel/Region)

24.4.15.4. Sales Footprint

24.4.15.5. Strategy Overview

24.4.15.5.1. Marketing Strategy

24.4.15.5.2. Drug Strategy

24.4.15.5.3. Channel Strategy

25. Assumptions and Acronyms Used

26. Research Methodology